Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Ralf Koberstein has worked on the following 20 EPO patent applications which have been published in the last five years:

EP12722194

7-(HETEROARYL-AMINO)-6,7,8,9-TETRAHYDROPYRIDO[1,2-A]INDOL ACETIC ACID DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS

IPC classification:
A61K 31/437, A61P 37/08, C07D 471/04
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
PATENT GRANTED
EP12756563

HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4355, A61K 31/436, A61P 29/00, C07D 491/048, C07D 491/052
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12823031

HETEROCYCLYL DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS

IPC classification:
A61K 31/47, C07D 209/44, C07D 217/06, C07D 223/06, C07D 223/16, C07D 401/06, C07D 401/12, C07D 405/06, C07D 413/06, C07D 417/06
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
PATENT GRANTED
EP13707053

HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4355, A61P 29/00, C07D 491/048
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13712913

4-(BENZOIMIDAZOL-2-YL)-THIAZOLE COMPOUNDS AND RELATED AZA DERIVATIVES

IPC classification:
A61K 31/427, C07D 417/14, C07D 471/04, C07D 487/04, C07D 519/00
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
PATENT GRANTED
EP13731930

1-(P-TOLYL)CYCLOPROPYL SUBSTITUTED BRIDGED SPIRO[2.4]HEPTANE DERIVATIVES AS ALX RECEPTOR AGONISTS

IPC classification:
A61K 31/40, A61P 3/00, C07D 207/08, C07D 207/10
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
PATENT GRANTED
EP13731938

FLUORINATED BRIDGED SPIRO[2.4]HEPTANE DERIVATIVES AS ALX RECEPTOR AGONISTS

IPC classification:
A61K 31/40, A61K 31/44, A61P 9/00, A61P 29/00, A61P 31/12, C07D 207/34, C07D 211/58
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
PATENT GRANTED
EP13762258

1-PHENYL-SUBSTITUTED HETEROCYCLYL DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS

IPC classification:
A61K 31/4353, A61P 11/00, A61P 17/00, A61P 37/00, C07D 513/04
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
EXAMINATION IN PROGRESS
EP13826623

INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/404, A61P 29/00, C07D 209/08, C07D 209/24
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
PATENT GRANTED
EP14703442

HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/428, A61K 31/429, A61P 29/00, C07D 277/60, C07D 513/04
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
PATENT GRANTED
EP14706331

HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS& xA;

IPC classification:
A61K 31/428, A61K 31/429, A61P 25/00, A61P 29/00, C07D 277/60
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
PATENT GRANTED
EP14732206

DIFLUOROETHYL-OXAZOLE SUBSTITUTED BRIDGED SPIRO[2.4]HEPTANE DERIVATIVES AS ALX RECEPTOR AGONISTS

IPC classification:
A61K 31/422, C07D 413/12
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
PATENT GRANTED
EP14739472

PIPERAZINE SUBSTITUTED BRIDGED SPIRO[2.4]HEPTANE DERIVATIVES AS ALX RECEPTOR AGONISTS

IPC classification:
A61K 31/495, C07D 295/14
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
GRANT OF PATENT INTENDED
EP14781943

BENZIMIDAZOLYL-METHYL UREA DERIVATIVES AS ALX RECEPTOR AGONISTS

IPC classification:
A61K 31/4184, A61P 29/00, C07D 235/14, C07D 401/12, C07D 403/12, C07D 405/12, C07D 413/12, C07D 417/12, C07D 453/02, C07D 471/04, C07D 473/00
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
PATENT GRANTED
EP15714032

AZAINDOLE ACETIC ACID DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS

IPC classification:
A61K 31/437, A61P 37/00, C07D 471/04
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
EXAMINATION REQUESTED
EP15714030

AZAINDOLE ACETIC ACID DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS

IPC classification:
A61K 31/437, A61P 37/00, C07D 471/04
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
EXAMINATION REQUESTED
EP15714957

8-(PIPERAZIN-1-YL)-1,2,3,4-TETRAHYDRO-ISOQUINOLINE DERIVATIVES

IPC classification:
A61K 31/4725, A61P 25/28, A61P 35/00, A61P 37/00, C07D 401/14, C07D 413/14, C07D 417/14, C07D 471/04
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
EXAMINATION REQUESTED
EP15728640

PYRAZOLE COMPOUNDS AND THEIR USE AS T-TYPE CALCIUM CHANNEL BLOCKERS

IPC classification:
A61K 31/415, A61K 31/4155, A61K 31/4439, A61P 3/10, A61P 9/00, A61P 15/00, A61P 25/00, A61P 35/00, C07D 231/40, C07D 401/06, C07D 401/12, C07D 401/14, C07D 403/12, C07D 405/12, C07D 405/14, C07D 413/12, C07D 471/04
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Status:
EXAMINATION REQUESTED
EP15763321

TRIAZOLE COMPOUNDS AS T-TYPE CALCIUM CHANNEL BLOCKERS

IPC classification:
A61K 31/4192, A61P 9/00, A61P 35/00, C07D 249/04, C07D 401/12, C07D 403/12, C07D 405/12
Agent:
Ralf Koberstein, Actelion Pharmaceuticals Ltd.
Agent:
Ralf Koberstein, Idorsia Pharmaceuticals Ltd
Status:
Request for examination was made

Please Sign in to use this feature